Integral Health Asset Management, LLC Karyopharm Therapeutics Inc. Transaction History

Integral Health Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $667,500 - $1.59 Million	-150,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$8.11 - $11.11 $1.22 Million - $1.67 Million	-150,000 Reduced 50.0%	150,000 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $2.03 Million - $2.78 Million	250,000 Added 500.0%	300,000 $3.1 Million
Q1 2021 May 10, 2021	SELL	$9.85 - $17.69 $492,500 - $884,500	-50,000 Reduced 50.0%	50,000 $526,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $1.06 Million - $1.29 Million	-75,000 Reduced 42.86%	100,000 $1.55 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1.41 Million - $1.97 Million	100,000 Added 133.33%	175,000 $2.56 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $415,000 - $631,250	-25,000 Reduced 25.0%	75,000 $1.42 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $3.52 Million - $6.79 Million	-245,000 Reduced 71.01%	100,000 $1.92 Million
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $3.18 Million - $6.79 Million	345,000 New	345,000 $6.61 Million

59.6M

547K

67K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $611M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.